A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : KPC / K. pneumoniae carbapenemase

[Related PubMed/MEDLINE]
Total Number of Papers: 65
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   KPC  (>> Co-occurring Abbreviation)
Long Form:   K. pneumoniae carbapenemase
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of beta-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens. CLSI, ESBL, EUCAST, MBL
2020 In vivo acquisition and risk of inter-species spread of bla KPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract. ---
2020 Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats. ESBL
2020 The First blaKPC Harboring Klebsiella pneumoniae ST258 Strain Isolated in Pakistan. ST258
2019 Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae. FICI, MIC:MIC, NDM, OXA, SBPI
2019 Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017. BSI, CPE, IR
2019 Effects of KPC Variant and Porin Genotype on the In Vitro Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae. CRE, RUO
2019 Identification of potential inhibitors for Klebsiella pneumoniae carbapenemase-3: a molecular docking and dynamics study. K. pneumoniae
2019 Klebsiella pneumoniae and Klebsiella quasipneumoniae define the population structure of blaKPC-2Klebsiella: a 5 year retrospective genomic study in Singapore. CG, clb, Ybt
10  2019 Molecular typing of a large nosocomial outbreak of KPC-producing bacteria in the biggest tertiary-care hospital of Quito, Ecuador. CLSI, INSPI, MLST
11  2019 The role of the bla KPC gene in antimicrobial resistance of Klebsiella pneumoniae. MHT, MICs
12  2019 Two Hypervirulent Klebsiella pneumoniae Isolates Producing a bla KPC-2 Carbapenemase from a Canadian Patient. ---
13  2018 Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City. MICs
14  2018 Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: A retrospective review. CoNS, MDROs, NICU
15  2018 Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan. MICs
16  2018 Epidemiology of and risk factors for infection with extended-spectrum beta-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case-control study. CRE, ESBL, IMP, NDM, OXA
17  2018 Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece. MBL, MLST, PFGE
18  2018 KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India. ---
19  2018 Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016). CRE, NDM, ST
20  2018 Prevalence of blaKPC and its occurrence with other beta-lactamases in Klebsiella pneumoniae. K. pneumoniae, PCR
21  2017 Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015. CRE, ESBL, MDR, PHP, VAP, XDR
22  2017 Antimicrobial Susceptibility and Molecular Epidemiology of Multidrug-Resistant Klebsiella pneumoniae in Central China. ESBL
23  2017 Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks. CRE, ST258
24  2017 Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series. KP
25  2016 A ten-year surveillance study of carbapenemase-producing Klebsiella pneumoniae in a tertiary care Greek university hospital: predominance of KPC- over VIM- or NDM-producing isolates. KPC-Kp, NDM, VIM
26  2016 An Irish outbreak of New Delhi metallo-beta-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence. CPE, MICs, NDM, NDM-1
27  2016 Characterization of ST258 Colistin-Resistant, blaKPC-Producing Klebsiella pneumoniae in a Greek Hospital. COL-R CP-Kp, ICU, MDR
28  2016 Extended-spectrum antibodies protective against carbapenemase-producing Enterobacteriaceae. CRE, PNAG
29  2016 High Gastrointestinal Colonization Rate with Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Emergence of Carbapenemase-Producing K. pneumoniae in Ethiopia. ESBL, ESBL-E
30  2016 High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae. CnsKP, MIC
31  2016 KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey. MLST, PFGE
32  2016 Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs. ---
33  2016 Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of beta-Lactamase-producing Klebsiella pneumoniae. EGCG, ESBL
34  2015 Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City. ---
35  2015 Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008-2012. Results of the Study for Monitoring Antimicrobial Resistance Trends. ESBL, IAIs
36  2015 Complete Genome Sequence of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Myophage Miro. ---
37  2015 Extensive Capsule Locus Variation and Large-Scale Genomic Recombination within the Klebsiella pneumoniae Clonal Group 258. CG, cps, IS, STs
38  2015 Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System. CRE, Inc, SNP
39  2015 Interactions of Klebsiella pneumoniae with the innate immune system vary in relation to clone and resistance phenotype. IL-1beta, MDR, MLST, PBMCs, ST383, TLR9, TNF-alpha, VIM
40  2015 Multi-drug-resistant Klebsiella pneumoniae pancreatitis: a new challenge in a serious surgical infection. ESBLs, MDR, SAP
41  2015 Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road? ---
42  2014 Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012. ESBL
43  2014 Comparative Evaluation of Multiplex PCR and Routine Laboratory Phenotypic Methods for Detection of Carbapenemases among Gram Negative Bacilli. CDT, MBL, MHT
44  2014 Genome Sequences of Two Carbapenemase-Resistant Klebsiella pneumoniae ST258 Isolates. ST258
45  2014 Improving the efficiency of the modified Hodge test in KPC-producing Klebsiella pneumoniae isolates by incorporating an EDTA disk. MHT
46  2014 Molecular characterization of clinical multidrug-resistant Klebsiella pneumoniae isolates. 16S-RMTase, ESBLs, MDR, MLST, PBRT, PCR, PFGE, PMQR, ST
47  2014 Multiplex PCR for identification of two capsular types in epidemic KPC-producing Klebsiella pneumoniae sequence type 258 strains. ST258
48  2013 Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. ST258
49  2013 Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series. NSTI
50  2013 Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. ---
51  2012 First report of KPC-producing Klebsiella pneumoniae in Croatia. ---
52  2012 [Carbapenemases among Klebsiella pneumoniae: sensitivity, E-test and Hodge test]. ESBL, ETP, IMP
53  2012 [Clinical and epidemiological study of an outbreak of KPC-producing Klebsiella pneumoniae infection in Buenos Aires, Argentina]. APB, ICU, PFGE
54  2011 Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. ---
55  2011 High burden of antimicrobial resistance in Asia. ESBL, MDR, MRSA, NDM-1, XDR-TB
56  2011 Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea. ESBL, ST
57  2011 Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid. ARB-PCR, CRE
58  2011 Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital. DOR, ERT, KP
59  2011 Plasmid comparison and molecular analysis of Klebsiella pneumoniae harbouring bla(KPC) from New York City and Toronto. MDR, MLST, NYC, OMP, rep
60  2010 Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. ST
61  2010 Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model. HPLC
62  2010 In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae. ---
63  2009 Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission. ---
64  2009 Multidrug-resistant Gram-negative infections: what are the treatment options? ESBL, MDR, PK/PD
65  2007 The continuing challenge of ESBLs. ESBLs